Check our latest special series eBook – this time focusing on biopharmaceutical drug development. First, we put the focus on vaccines by speaking with Moncef Slaoui, who’s been involved in major projects including Shringrix and the US’s Operation Warp Speed.
We also find out how mRNA science is impacting the development of protein therapeutics. An expert from Nutcracker Therapeutics believes that: “mRNA-based protein design offers the most flexible path forward for designing drugs that overcome the barriers and challenges associated with durable treatments.”
In addition, the eBook features content on accelerating cell line development, vial choice for frozen biopharmaceutical storage, the complexity of antibody drug conjugates, and what the future will hold for biopharma drug development as a whole.